FIELD: chemistry.
SUBSTANCE: invention relates to microbiological industry and can be used in biotechnology, genetic engineering, medicine and veterinary. Claimed is application of RNAase Bacillus sp. VKPM B-9862 as preparation for selective apoptotic elimination of tumour cells.
EFFECT: claimed preparation possesses expressed apoptosis-inducing action with respect to malignant cells, without producing toxic effect on normal cells of blood, liver, nervous tissue and fibroblasts.
4 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STREPTOMYCIN-RESISTANT STRAIN Bacillus sp ARCIM B-9862, PRODUCER OF EXTRACELLULAR ALKALINE RIBONUCLEASE | 2008 |
|
RU2384619C1 |
| METHOD FOR DEVELOPING ALZHEIMER DISEASE CELL MODELS | 2013 |
|
RU2544957C2 |
| METHOD FOR TREATING MALIGNANT TUMORS IN ANIMALS | 2006 |
|
RU2317825C1 |
| METHOD OF APOPTOSIS STIMULATION | 2006 |
|
RU2340349C2 |
| RECOMBINANT PLASMID DNA pcDNA4-Apo-2NLS2 CARRYING SYNTHETIC GENE OF APOPTIN PROTEIN INDUCING p53-INDEPENDENT PROGRAMMED TUMOUR CELL DEATH | 2013 |
|
RU2541777C1 |
| COMBINED THERAPY PAC-1 | 2016 |
|
RU2720509C2 |
| APOPTOSIN AND ANTIOXIDANT COMPOSITION | 2017 |
|
RU2682644C2 |
| USE OF COMPOSITION OF COPPER OXIDE NANOPARTICLES AND N-ACETYLCYSTEINE FOR DEATH INDUCTION OF CELLS OF CHRONIC MYELOID LEUKAEMIA | 2019 |
|
RU2721771C1 |
| AGENT HAVING CYTOSTATIC AND APOPTOSIS-INDUCING ACTIVITY | 2005 |
|
RU2296578C2 |
| RECOMBINANT SARS-CoV-2 S PROTEIN RBD-BINDING PROTEIN | 2022 |
|
RU2778942C1 |
